Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug ...
After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...
Erste Group analyst Hans Engel upgraded Amgen (AMGN) to Buy from Hold. Amgen has a higher operating margin and a higher return on equity than ...
Amgen Inc.'s ( NASDAQ:AMGN ) dividend will be increasing from last year's payment of the same period to $2.38 on 7th ...
StockStory.org on MSN20h
Why Amgen (AMGN) Stock Is Trading Up TodayWhat Happened? Shares of biotech company Amgen (NASDAQ:AMGN) jumped 5.3% in the morning session after the company reported ...
The Dow Jones Industrial Average is climbing Wednesday afternoon with shares of Amgen and NVIDIA Corp. seeing positive growth for the index.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...
Morgan Stanley analyst Terence Flynn raised the firm’s price target on Amgen (AMGN) to $328 from $322 and keeps an Equal Weight rating on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback